[at noodls] – WALTHAM, Mass., Nov. 19, 2013 (GLOBE NEWSWIRE) — Repligen Corporation today announced that it has elected to its Board of Directors John G. Cox, Executive Vice President of Pharmaceutical Operations & …
Read more on this.
Biogen Idec Inc. (BIIB), … [visit site to read more]
Similar posts:- Biogen Idec Inc. (NASDAQ:BIIB) | Better Buy: Biogen or Amgen?
- Company Update: Biogen Idec Inc. (NASDAQ:BIIB) – BIIB December 6th Options Begin Trading
- Company Update: Biogen Idec Inc. (NASDAQ:BIIB) – Multiple Of 40x Earnings Gives Biogen Idec The Wobblies